Stocks
Sanofi (SNY) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 27.5% | 32.1% | 31.0% | 34.2% | 30.1% | 27.5% | ||
| Changes by years, y/y, % | -4pp | +5pp | -1pp | +3pp | -4pp | -0.8% | |||
Sanofi. EBITDA margin, %
Sanofi. EBITDA margin, changes, pp
Sanofi (SNY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 26.5% | 26.5% | 32.8% | 26.0% | 25.8% | 27.5% | |
| Changes by years, y/y, % | +2pp | +2pp | -8pp | +0pp | -7pp | |||
| Changes by quarters, q/q, % | -6pp | 0pp | +6pp | -7pp | 0pp | |||
